This page contains the meeting materials for the Cardiovascular & Renal Drugs Advisory Committee meetings for 2023.
Similar Posts
Aspiration System Correction: Calyxo Updates Use Instructions for CVAC Aspiration Systems
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramPDUFA and BsUFA Quarterly Hiring Updates
PDUFA and BsUFA Quarterly Hiring UpdatesM14 General Principles on Planning, Designing, Analyzing, and Reporting of Non-interventional Studies That Utilize Real-World Data for Safety Assessment of Medicines
M14 General Principles on Planning, Designing, Analyzing, and Reporting of Non-interventional Studies That Utilize Real-World Data for Safety Assessment of MedicinesHillside Orchard Farms Recalls Various Fruit Breads & Fritters Due to Undeclared Egg
Tiger GA – July 28, 2025 – Hillside Orchard Farms is recalling various flavors of their 23oz Fruit Breads & 7.5 oz Fritters due to an undeclared allergen of Egg. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reaction if they consume theReplacing and Reducing Animal Testing at CDER
It has become increasingly clear that new approach methodologies (NAMs)—when combined with knowledge of the pathway, results of pharmacology studies, and other relevant data—may offer ways to reduce animal testing.Primal Herbs Volume may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Primal Herbs Volume, a product promoted and sold for sexual enhancement on various websites, including primalherbs.com, and possibly in some retail stores.